Insider: ROBERTS EIRY Chief Medical Officer - NEUROCRINE BIOSCIENCES INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 35,640 | 0 | 35,640 |
| Value | $5,021,319.60 | $0.00 | $5,021,319.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/14/2025 | DDS | 500 | Direct | COM | $115.04 | $57,521.25 | 35,640 |
| 02/13/2025 | DDS | 1,114 | Direct | COM | $116.90 | $130,232.06 | 34,252 |
| 02/13/2025 | DDS | 604 | Direct | COM | $116.74 | $70,510.42 | 34,768 |
| 02/10/2025 | DDS | 980 | Direct | COM | $118.22 | $115,852.66 | 33,253 |
| 01/31/2025 | DDS | 1,457 | Direct | COM | $152.80 | $222,636.16 | 32,373 |
| 02/13/2024 | DDS | 1,114 | Direct | COM | $132.96 | $148,121.78 | 23,716 |
| 02/08/2024 | DDS | 980 | Direct | COM | $134.21 | $131,521.98 | 22,717 |
| 02/06/2024 | DDS | 1,121 | Direct | COM | $142.24 | $159,446.11 | 21,837 |
| 01/31/2024 | DDS | 1,457 | Direct | COM | $140.79 | $205,131.90 | 20,832 |
| 12/22/2023 | DDS | 10,000 | Direct | COM | $126.74 | $1,267,448.00 | 19,521 |
| 12/12/2023 | DDS | 6,947 | Direct | COM | $120.31 | $835,778.98 | 29,521 |
| 12/12/2023 | DDS | 6,978 | Direct | COM | $120.30 | $839,461.08 | 29,521 |
| 12/08/2023 | DDS | 200 | Direct | COM | $120.16 | $24,031.00 | 29,521 |
| 12/08/2023 | DDS | 100 | Direct | COM | $120.00 | $12,000.00 | 29,521 |
| 12/07/2023 | DDS | 38,722 | Direct | COM | $120.37 | $4,661,118.16 | 29,521 |
| 12/07/2023 | DDS | 12,742 | Direct | COM | $120.37 | $1,533,773.65 | 29,521 |
| 12/07/2023 | DDS | 11,775 | Direct | COM | $120.37 | $1,417,374.41 | 29,521 |
| 12/07/2023 | DDS | 14,140 | Direct | COM | $120.37 | $1,702,053.01 | 29,521 |
| 12/06/2023 | DDS | 8,396 | Direct | COM | $120.03 | $1,007,780.28 | 29,521 |
| 08/21/2023 | DDS | 3,198 | Direct | COM | $107.38 | $343,387.81 | 29,521 |
| 04/24/2023 | DDS | 14,400 | Direct | COM | $103.48 | $1,490,058.72 | 26,644 |
| 02/08/2023 | DDS | 980 | Direct | COM | $104.16 | $102,072.00 | 41,015 |
| 02/07/2023 | DDS | 1,623 | Direct | COM | $102.35 | $166,114.05 | 28,638 |
| 02/07/2023 | DDS | 12,801 | Direct | COM | $102.41 | $1,310,918.41 | 40,135 |
| 02/06/2023 | DDS | 1,121 | Direct | COM | $105.80 | $118,602.25 | 27,176 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research